David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$9.63B |
| 2 |
Amazon
AMZN
|
+$1.56B |
| 3 |
NVIDIA
NVDA
|
+$1.1B |
| 4 |
Meta Platforms (Facebook)
META
|
+$924M |
| 5 |
SPCX
SpaceX
SPCX
|
+$907M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$2.17B |
| 2 |
Broadcom
AVGO
|
+$1.53B |
| 3 |
Microsoft
MSFT
|
+$1.05B |
| 4 |
TSMC
TSM
|
+$928M |
| 5 |
Texas Instruments
TXN
|
+$904M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.78% |
| 2 | Financials | 8.35% |
| 3 | Healthcare | 7.91% |
| 4 | Consumer Discretionary | 7.83% |
| 5 | Industrials | 7.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3326
Huazhu Hotels Group
HTHT
$15.1B
| $1.5M | ﹤0.01% |
+36,068
| New | +$1.72M |
|
|
BCPC
3327
Balchem Corp
BCPC
$5.78B
| $1.5M | ﹤0.01% |
8,897
-31,371
| -78% | -$5.21M |
|
3328
CALL
Constellation Brands
STZ
$23.2B
| $1.5M | ﹤0.01% |
10,800
-26,800
| -71% | -$3.98M |
|
3329
Ginkgo Bioworks
DNA
$498M
| $1.5M | ﹤0.01% |
151,356
+124,187
| +457% | +$1.04M |
|
|
PECE
3330
Peace Acquisition Corp
PECE
$84.1M
| $1.5M | ﹤0.01% |
+151,000
| New | +$1.5M |
|
|
IGAC
3331
Invest Green Acquisition Corp
IGAC
$240M
| $1.49M | ﹤0.01% |
149,197
+48,400
| +48% | +$483K |
|
3332
PUT
Altria Group
MO
$110B
| $1.49M | ﹤0.01% |
20,700
-73,800
| -78% | -$5.15M |
|
3333
Invesco QQQ Trust
QQQ
$487B
| $1.49M | ﹤0.01% |
+2,022
| New | +$1.39M |
|
3334
PUT
Materion
MTRN
$4.83B
| $1.49M | ﹤0.01% |
+5,000
| New | +$1.05M |
|
3335
Inovio Pharmaceuticals
INO
$122M
| $1.49M | ﹤0.01% |
1,351,656
-861,163
| -39% | -$1.02M |
|
3336
Eos Energy Enterprises
EOSE
$1.39B
| $1.49M | ﹤0.01% |
252,636
+105,197
| +71% | +$732K |
|
3337
American Vanguard Corp
AVD
$67.9M
| $1.48M | ﹤0.01% |
530,006
+26
| +0% | +$71 |
|
3338
Choiceone Financial
COFS
$496M
| $1.48M | ﹤0.01% |
43,598
-4,013
| -8% | -$125K |
|
3339
Nelnet
NNI
$4.55B
| $1.48M | ﹤0.01% |
11,109
-9,271
| -45% | -$1.23M |
|
3340
PUT
PennyMac Financial
PFSI
$3.9B
| $1.48M | ﹤0.01% |
+17,000
| New | +$1.48M |
|
|
ONIT
3341
Onity Group
ONIT
$301M
| $1.48M | ﹤0.01% |
37,225
+12,553
| +51% | +$495K |
|
3342
Benchmark Electronics
BHE
$2.61B
| $1.48M | ﹤0.01% |
14,989
-41,931
| -74% | -$3.34M |
|
3343
RE/MAX Holdings
RMAX
$290M
| $1.48M | ﹤0.01% |
149,751
-318,080
| -68% | -$2.78M |
|
3344
PUT
Equifax
EFX
$22.6B
| $1.48M | ﹤0.01% |
+9,300
| New | +$1.59M |
|
3345
Alamo Group
ALG
$2B
| $1.48M | ﹤0.01% |
8,973
+1,000
| +13% | +$162K |
|
|
RDAC
3346
Rising Dragon Acquisition Corp
RDAC
$39.9M
| $1.47M | ﹤0.01% |
273,125
| – | – |
|
3347
PUT
Macy's
M
$6B
| $1.47M | ﹤0.01% |
62,600
-315,000
| -83% | -$6.59M |
|
3348
PUT
BlackSky Technology
BKSY
$1.14B
| $1.47M | ﹤0.01% |
52,800
| – | – |
|
3349
FIVE9
FIVN
$2.45B
| $1.47M | ﹤0.01% |
69,058
-6,766
| -9% | -$134K |
|
3350
CALL
MetLife
MET
$60B
| $1.47M | ﹤0.01% |
+17,400
| New | +$1.4M |
|
Similar funds
David Shaw's Q2 2026 Portfolio in Review
As of Q2 2026, David Shaw held 5,360 positions worth $210B, up 26% from $166B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
David Shaw deployed $7.01B of net new capital in Q2 2026, opening 872 new positions and adding to 1,718 existing holdings. Its largest new stake was SpaceX: 5,340,000 shares worth $912M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Micron Technology, an estimated $2.17B trimmed.
- David Shaw's largest Q2 2026 buy was SpaceX: 5,340,000 shares worth $912M.
- David Shaw added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $9.63B increase.
- David Shaw's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $2.17B.
- David Shaw fully exited Automatic Data Processing in Q2 2026, selling an estimated $241M.
- David Shaw's ten largest holdings make up 15% of its $210B portfolio in Q2 2026.
- David Shaw opened 872 new positions and closed 527 in Q2 2026.
- David Shaw's portfolio value rose 26% quarter-over-quarter to $210B.
Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.